These inhibitors are important for their potential therapeutic applications, particularly in treating diseases characterized by excessive inflammatory responses, such as cancer, autoimmune diseases, and chronic inflammatory conditions. The role of the NF-κB pathway in various pathologies makes IκB kinase inhibitors a significant focus of research and development.
